Cancer Gene Therapy <em>Cancer Gene Therapy</em> is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA &amp; ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. <em>Cancer Gene Therapy</em> publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Articles published include the fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor. http://feeds.nature.com/cgt/rss/current Nature Publishing Group en © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. Cancer Gene Therapy © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. permissions@nature.com Cancer Gene Therapy https://www.nature.com/uploads/product/cgt/rss.png http://feeds.nature.com/cgt/rss/current <![CDATA[Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: A real-world study]]> https://www.nature.com/articles/s41417-024-00752-0 Cancer Gene Therapy, Published online: 28 March 2024; doi:10.1038/s41417-024-00752-0

Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: A real-world study]]>
Zhiqiang SongYang WangPing LiuYuke GengNa LiuJie ChenJianmin Yang doi:10.1038/s41417-024-00752-0 Cancer Gene Therapy, Published online: 2024-03-28; | doi:10.1038/s41417-024-00752-0 2024-03-28 Cancer Gene Therapy 10.1038/s41417-024-00752-0 https://www.nature.com/articles/s41417-024-00752-0
<![CDATA[Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer]]> https://www.nature.com/articles/s41417-024-00756-w Cancer Gene Therapy, Published online: 26 March 2024; doi:10.1038/s41417-024-00756-w

Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer]]>
Masanori OshiArya Mariam RoyLi YanSachika KinoshitaYuko TamuraTakashi KosakaHirotoshi AkiyamaChikara KunisakiKazuaki TakabeItaru Endo doi:10.1038/s41417-024-00756-w Cancer Gene Therapy, Published online: 2024-03-26; | doi:10.1038/s41417-024-00756-w 2024-03-26 Cancer Gene Therapy 10.1038/s41417-024-00756-w https://www.nature.com/articles/s41417-024-00756-w
<![CDATA[Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers]]> https://www.nature.com/articles/s41417-024-00761-z Cancer Gene Therapy, Published online: 18 March 2024; doi:10.1038/s41417-024-00761-z

Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers]]>
Hongge LiangYan XuJing ZhaoMinjiang ChenMengzhao Wang doi:10.1038/s41417-024-00761-z Cancer Gene Therapy, Published online: 2024-03-18; | doi:10.1038/s41417-024-00761-z 2024-03-18 Cancer Gene Therapy 10.1038/s41417-024-00761-z https://www.nature.com/articles/s41417-024-00761-z
<![CDATA[Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications]]> https://www.nature.com/articles/s41417-024-00764-w Cancer Gene Therapy, Published online: 18 March 2024; doi:10.1038/s41417-024-00764-w

Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications]]>
Fatema SafriRomario NguyenShadi ZerehpooshnesfchiJacob GeorgeLiang Qiao doi:10.1038/s41417-024-00764-w Cancer Gene Therapy, Published online: 2024-03-18; | doi:10.1038/s41417-024-00764-w 2024-03-18 Cancer Gene Therapy 10.1038/s41417-024-00764-w https://www.nature.com/articles/s41417-024-00764-w
<![CDATA[The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers]]> https://www.nature.com/articles/s41417-024-00763-x Cancer Gene Therapy, Published online: 16 March 2024; doi:10.1038/s41417-024-00763-x

The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers]]>
Domenica RonchettiValentina TrainiIlaria SilvestrisGiuseppina FabbianoFrancesco PassamontiNiccolò BolliElisa Taiana doi:10.1038/s41417-024-00763-x Cancer Gene Therapy, Published online: 2024-03-16; | doi:10.1038/s41417-024-00763-x 2024-03-16 Cancer Gene Therapy 10.1038/s41417-024-00763-x https://www.nature.com/articles/s41417-024-00763-x
<![CDATA[MISEV2023: Shaping the Future of EV Research by Enhancing Rigour, Reproducibility and Transparency]]> https://www.nature.com/articles/s41417-024-00759-7 Cancer Gene Therapy, Published online: 14 March 2024; doi:10.1038/s41417-024-00759-7

MISEV2023: Shaping the Future of EV Research by Enhancing Rigour, Reproducibility and Transparency]]>
Mark SamuelsGeorgios Giamas doi:10.1038/s41417-024-00759-7 Cancer Gene Therapy, Published online: 2024-03-14; | doi:10.1038/s41417-024-00759-7 2024-03-14 Cancer Gene Therapy 10.1038/s41417-024-00759-7 https://www.nature.com/articles/s41417-024-00759-7
<![CDATA[Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT]]> https://www.nature.com/articles/s41417-024-00753-z Cancer Gene Therapy, Published online: 13 March 2024; doi:10.1038/s41417-024-00753-z

Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT]]>
Ying-Yu KuoChieh HuoChia-Yang LiChih-Pin Chuu doi:10.1038/s41417-024-00753-z Cancer Gene Therapy, Published online: 2024-03-13; | doi:10.1038/s41417-024-00753-z 2024-03-13 Cancer Gene Therapy 10.1038/s41417-024-00753-z https://www.nature.com/articles/s41417-024-00753-z
<![CDATA[Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis]]> https://www.nature.com/articles/s41417-024-00751-1 Cancer Gene Therapy, Published online: 13 March 2024; doi:10.1038/s41417-024-00751-1

Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis]]>
Marcela S. WernerShweta ArasAshleigh R. MorganJillian RoamerNesteene J. ParamKanyin OlagbegiR. Jason LamontagneJenny A. GreigJames M. Wilson doi:10.1038/s41417-024-00751-1 Cancer Gene Therapy, Published online: 2024-03-13; | doi:10.1038/s41417-024-00751-1 2024-03-13 Cancer Gene Therapy 10.1038/s41417-024-00751-1 https://www.nature.com/articles/s41417-024-00751-1